Skip to main content

Table 2 Factors associated with satisfaction with treatment cost

From: Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry

  

Univariate

Multivariate

Subjective model

Objective model

OR

95% CI

p-value

OR

95% CI

p-value

OR

95% CI

p-value

Common variables

 Age (years)

< 50

Ref

Ref

Ref

50–64

0.77

0.62–0.97

0.023

0.78

0.62–0.99

0.037

0.91

0.71–1.15

0.410

65–74

0.45

0.36–0.57

< 0.001

0.43

0.34–0.54

< 0.001

0.55

0.44–0.70

< 0.001

≥ 75

0.27

0.21–0.35

< 0.001

0.25

0.19–0.33

< 0.001

0.35

0.27–0.47

< 0.001

 Sex

Female

0.97

0.80–1.18

0.791

0.86

0.70–1.05

0.138

0.81

0.65–0.99

0.041

 Disease duration (years)

≥ 11

0.89

0.77–1.04

0.138

1.02

0.87–1.19

0.841

1.06

0.88–1.28

0.549

Subjective variables

 Pain VAS (cm)

> 1.2

1.34

1.15–1.554

< 0.001

1.19

0.98–1.45

0.088

 General VAS (cm)

> 0.9

1.16

1.00–1.35

0.047

1.01

0.84–1.23

0.900

 EQ5D score

0.9–1.0

Ref

Ref

0.85–0.89

1.51

1.14–2.00

0.004

1.52

1.14–2.03

0.004

0.75–0.84

1.49

1.22–1.81

< 0.001

1.54

1.24–1.90

< 0.001

0–0.74

1.17

0.97–1.42

0.109

1.27

1.01–1.59

0.044

Objective variables

 TJC

≥ 1

1.31

1.12–1.53

< 0.001

1.04

0.86–1.27

0.665

 SJC

≥ 1

1.42

1.28–1.66

< 0.001

1.36

1.12–1.66

0.002

 Log-transformed CRP (mg/dL)

Continuous

0.88

0.84–0.93

< 0.001

0.92

0.87–0.98

0.006

 Physician VAS (cm)

> 0.5

1.26

1.08–1.46

0.003

1.33

1.10–1.61

0.003

 Steinbrocker stage

3 and 4

0.87

0.74–1.01

0.069

0.84

0.69–1.03

0.100

 Musculoskeletal surgery

Yes

0.57

0.47–0.69

< 0.001

0.60

0.48–0.74

< 0.001

 Prednisolone dose (mg)

> 5

1.14

0.81–1.62

0.454

1.16

0.81–1.68

0.413

 Methotrexate use

Yes

0.95

0.80–1.12

0.515

0.90

0.76–1.08

0.256

 b/tsDMARDs use

Yes

2.47

2.10–2.91

< 0.001

2.21

1.85–2.65

< 0.001

  1. OR odds ratio, 95% CI 95% confidence interval